
Download Complimentary Report Summary
Today's MSLs are key strategic drivers for diabetes products' and overall company success. Currently, approximately 246 million people worldwide have diabetes; this number is expected to increase to 380 million by 2025, according to the International Diabetes Foundation. Such staggering figures solidify diabetes' position as a primary therapeutic area. They also indicate the value of medical science liaisons who are building relationships within the diabetes medical community.
Perhaps your company plans to enter a new market or maybe your diabetes MSL team needs an upgrade. In either case, The Toolkit for Diabetes MSL Programs provides clear, easy-to-access guidance on all aspects of diabetes MSL program management. The research focuses on these core areas:
CEI has integrated its leading research in MSLs and thought leader management with a growing expertise in therapeutic areas to create a highly customized, data-driven report. You won't find this information anywhere else! Use The Toolkit for Diabetes MSL Programs to strengthen your diabetes MSL team's structure and operations.
Call Adam Bianchi at 919-403-6583 to get your own copy of "The Toolkit for Diabetes MSL Programs" today.